Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06490146 · ClinicalTrials.gov registry record

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function

A clinical trial of Menopause, sponsored by University of Minnesota.

Recruiting
Registry status
80
Enrollment target
1
Study location

NCT06490146: Recruiting study of Menopause, sponsored by University of Minnesota.

NCT06490146 is a study of Menopause that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 80 participants, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06490146, a study of Menopause, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

This is a longitudinal study to determine the influence of the menopause transition on autonomic and vascular function. PI Keller-Ross has published data demonstrating that postmenopausal females have greater sympathetic neural reactivity during a stressor compared with age-matched males and younger females and males. A paucity of literature exists, however, on the role of the menopause transition in autonomic function because the majority of experimental studies on menopause physiology are cross-sectional and/or focused on older, postmenopausal females . The influence of age on HTN is robust, whereas the effects of menopause are still unclear. Preliminary data demonstrate a clear association between age and sympathetic activity in females; how the transition through menopause influences these relations, however, remains unknown. The study will enroll 80 midlife (45-55 years of age) females to measure longitudinally the trajectory of autonomic and vascular function during the transition through menopause. The study hypothesizes that through the menopause transition, an increase in sympathetic activity and an impaired baroreflex sensitivity and endothelial function will emerge.

Primary Outcome

measured in bursts/min Microneurography to measure MSNA: Microneurography is a direct measurement of electrical activity of peripheral sympathetic nerves. A tungsten microelectrode is placed in a peripheral nerve (Figure 8) to record real-time activity from efferent sympathetic vasoconstrictor nerve fibers. MSNA is the gold-standard measure for sympathetic activity Participants attend experimental visits annually until they enter perimenopause, at which point they will attend such visits every

Conditions Studied

Interventions

  • OTHER No intervention

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-04-01
Est. Completion 2030-08-21
University of Minnesota

966 total trials

What NCT06490146 shows while recruiting

NCT06490146 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT06490146 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06490146 about?

NCT06490146 is a clinical study titled "Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function". This is a longitudinal study to determine the influence of the menopause transition on autonomic and vascular function. PI Keller-Ross has published data demonstrating that postmenopausal females have greater sympathetic neural reactivity during a stressor compared with age-matched males and younger...

What is the current status of trial NCT06490146?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-04-01. Estimated completion is 2030-08-21.

What conditions does trial NCT06490146 study?

This clinical trial studies the following conditions: Menopause.

What interventions are being tested in trial NCT06490146?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT06490146?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06490146 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06490146's enrollment target sits among peer trials

80 24th of 54 higher than 31 of 54 other Menopause trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06490146, the US trial registry maintained by the National Library of Medicine. NCT06490146 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.